TP53 and cancer: The occurrence of presentations without a familial cancer history can be attributed to two main factors: the contribution of de novo variants to the hTP53-related cancer syndrome, estimated to range from 7 to 20%, and the lacking in the penetrance of pathogenetic TP53 changes [57].